Back
Apellis Pharmaceuticals Vs. Braze Industry Stock Comparison
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
35.63
Seasonality Move:
15.53%
Sell
23
BRZE
Braze
Last Price:
35.03
Seasonality Move:
-2.96%
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $35.53. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Braze (BRZE)
is a Sell
Is Braze a Buy, Sell or Hold?
- The current Braze [BRZE] share price is $35.60. The Score for BRZE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- BRZE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $35.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
BRZE Stock Price Chart
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 39.84 | Sell |
Chaikin Money Flow: | -728829 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.93 - 39.81) | Sell |
Bollinger Bands (100): | (36.69 - 43.03) | Sell |
BRZE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.85 | Sell |
Relative Strength Index (14 RSI): | 36.45 | Sell |
Chaikin Money Flow: | 215605 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.76 - 45.1) | Sell |
Bollinger Bands (100): | (36.81 - 42.95) | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.1 | Sell |
20-day SMA: | 38.7 | Sell |
50-day SMA: | 38.06 | Sell |
200-day SMA: | 50.38 | Sell |
8-day EMA: | 37.4 | Sell |
20-day EMA: | 38.04 | Sell |
50-day EMA: | 38.67 | Sell |
200-day EMA: | 46.02 | Sell |
BRZE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.14 | Buy |
20-day SMA: | 40.69 | Sell |
50-day SMA: | 40.51 | Sell |
200-day SMA: | 45.87 | Sell |
8-day EMA: | 36.34 | Sell |
20-day EMA: | 38.77 | Sell |
50-day EMA: | 39.99 | Sell |
200-day EMA: | 42.69 | Sell |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
Braze Earnings Growth & BRZE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.42 per share, and an increase next year of $0.33 per share.
Apellis Pharmaceuticals Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Braze Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |